JP

Naoya Ono

This inventor holds 0 USPTO granted patents, plus 7 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoya Ono. Retrieved from https://idiyas.com/inventor/naoya-ono-kcj7fd0p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Naoya Ono: Innovator in Pharmaceutical Compounds

Introduction

Naoya Ono is a notable inventor based in Japan, recognized for his contributions to the field of pharmaceutical compounds. His innovative work focuses on developing novel therapeutics that address various medical conditions, particularly alopecia.

Latest Patents

Although Naoya Ono currently holds no patents, his latest inventions include significant advancements in the area of azole derivatives and prostaglandin derivatives. The azole derivative compounds are designed to bind to FKBP12, offering potential therapeutic applications in the prevention and treatment of alopecia. Specifically, these compounds are represented by a unique formula that includes various substituents, enhancing their efficacy. Additionally, his work on prostaglandin derivatives involves compounds characterized by a general formula that includes halogeno configurations and various alkyl groups, which may lead to new therapeutic options.

Career Highlights

Throughout his career, Naoya Ono has worked with prominent companies in the pharmaceutical industry, including Taisho Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative compounds that have the potential to improve patient outcomes.

Collaborations

Naoya Ono has collaborated with Fumie Sato, a fellow professional in the field. Their partnership has likely fostered the exchange of ideas and expertise, further enhancing the development of their pharmaceutical innovations.

Conclusion

Naoya Ono's work in pharmaceutical compounds showcases his commitment to innovation in the medical field. His contributions, particularly in the development of novel therapeutics, highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…